Summary:
Click image to enlarge
The purpose of this trials is to compare the safety and efficacy of two trial products (semaglutide and canagliflozin) in patients who have only received metformin as a treatment for their type 2 diabetes.
Qualified Participants Must:
• Be at least 18 years of age
•
Have type 2 diabetes, and have been treated with Metformin for at least 90 days
•
Be able to attend 9 clinic visits
Qualified Participants May Receive:
Comprehensive care including regular health checks and medical testing
Access to trial medication and blood glucose testing at no cost
May receive compensation for time and travel